#Urology Devices Market Growth
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Average visit duration of Tumblr.com is 10 mins and 25 secs.
Text
Urology Devices Market worth $48.6 billion by 2028
Urology Devices Market in terms of revenue was estimated to be worth $34.1 billion in 2023 and is poised to reach $48.6 billion by 2028, growing at a CAGR of 7.3% from 2023 to 2028 according to a new report by MarketsandMarkets. The high prevalence of urological diseases significantly impacts the increased demand for urological devices. Cancer patients who need surgical interventions with latest technologies like minimally invasive surgery and robotic surgeries. This will lead to an increased need for urological devices. Thus, the escalating demand for urological disease diagnosis and treatment, has led to a pressing need for technologically advanced devices, which is thereby expected to support the growth of the urological devices market.
Download an Illustrative overview:
Browse in-depth TOC on "Urology Devices Market"
159 - Tables
44 - Figures
274 – Pages
In 2022, the instruments segment held the largest share of the urology devices market by product segment.
The urology devices market is segmented into instruments and consumables & accessories based on products. The instruments segment accounted for the largest share of the urology devices market in 2022. This segment covers the most commonly used products, such as dialysis devices, endoscopes, laser & lithotripsy devices, endovision & imaging systems, robotic systems, insufflators, endoscopy fluid management systems, urodynamic systems and other instruments. These products are commonly used in hospitals, dialysis centers and home care settings. As technologies continue to evolve, the efficiency and accuracy of these products contribute significantly to the urological procedures.
The kidney diseases segment held the largest share of the urology devices market by application segment in 2022.
The global urology devices market is differentiated into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications. In 2022, the kidney diseases segment dominated the urology devices market. The urology devices market in kidney diseases is expected to grow at a high rate owing to the rising incidence of kidney diseases and chronic diseases. With a burgeoning global population, the need for urology devices has significantly increased due to the increased number of procedures required. Hospitals and dialysis centers are at the forefront of this surge, as they cater to routine medical care and handle emergencies.
The hospitals, ASCA & clinics segment held the largest share of the urology devices market by end-user segment in 2022.
The global urology devices market is differentiated into hospitals, ASCS & clinics, dialysis centers and home care settings. In 2022, the hospitals, ASCS & clinics segment dominated the urology devices market. The urology devices market in hospitals is expected to grow at a high rate owing to the increasing number of surgical procedures related to urology care. The expanding network of healthcare institutions directly translates to a substantial market share, reflecting the pivotal role hospitals play in safeguarding patient well-being.
North America is the largest regional market for urology devices market.
The market for urology devices has been divided into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the predominant portion of the urology devices market. This can be attributed to the region's advanced healthcare facilities and substantial healthcare investments, which are pivotal in fueling the requirement for urology devices. Moreover, the projected rise in urological procedures is anticipated to contribute to the expansion of the market. As the demand for urological procedures rises, so does the need for precise urological devices to ensure successful and safe procedures.
Request Sample Pages:
Urology Devices Market Dynamics:
Drivers:
Rising incidence of urological diseases
Growing preference for minimally invasive procedures
Rising focus on R&D and product launches
Growing number of hospitals and surgical centers
Restraints:
High degree of consolidation among key players
Opportunities:
Growing Potential growth opportunities in emerging economies
Technological advancements
Challenge:
Increasing number of product recalls by key players
Shortage of skilled urologists
Key Market Players of Urology Devices Industry:
The major players operating in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland), Karl Storz (Germany), Cook Medical (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Dialife SA (Switzerland), Erbe Vision (Germany), Well Lead Medical Co., Ltd. (China), ROCAMED (Germany), EndoMed Systems GmbH (Germany), Amniso International, Inc. (US), Medispec (US), Medical Technologies of Georgia (US), Vimex Sp. z o.o. (Poland), Balton Sp. z o.o. (Poland), Hunter Urology (UK), Ribbel International Ltd. (India).
Recent Developments of Urology Devices Industry
In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.
In December 2022, Boston Scientific Corporation (US) and Acotec Scientific Holdings Limited (China) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures.
In May 2022, B. Braun SE (Germany) entered into a distribution agreement, and B. Braun surgery division Aesculap has strengthened its long-term partnership with True Digital Surgery, a Californian company that is an expert in robotically controlled 3D digital visualization.
In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)
In April 2021, Becton, Dickinson and Company (US) announced an investment of USD 65 million for the construction of a state-of-the-art medical facility in Tucson, Arizona (US), which will serve as a final stage manufacturing and sterilization center to improve overall efficiency, customer service, and supply chain in the US.
Urology Devices Market - Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Rising incidence of urological diseases, growing preference for minimally invasive procedures, rising focus on R&D and product launches, growing number of hospitals and surgical centers), restraints (high degree of consolidation among key players), opportunities (potential growth opportunities in emerging economies, technological advancements) and challenges (increasing number of product recalls by key players, shortage of skilled urologists) influencing the growth of the urology devices market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urology devices market.
Market Development: Comprehensive information about lucrative markets – the report analyses the urology devices market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.
#Global Urology Devices Market#Urology Devices Industry#Urology Devices Market Size#Urology Devices Market Growth#Urology Devices Market Outlook
0 notes
Text
https://carbonfacesocial.org/blogs/69733/Urology-Devices-Market-Size-Overview-Share-and-Forecast-2031
The Urology Devices Market in 2023 is US$ 41.35 billion, and is expected to reach US$ 58 billion by 2031 at a CAGR of 4.30%.
0 notes
Text
Navigating the Dynamics of Urology Devices Market Industry
Market Overview –
The Urology Devices Market encompasses medical devices and equipment used in the diagnosis, treatment, and management of urological disorders and conditions affecting the urinary tract and male reproductive system. This includes devices for urinary incontinence, kidney stones, benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), erectile dysfunction, and other urological conditions.
One significant driver of the Urology Devices Market's growth is the increasing prevalence of urological disorders worldwide, driven by factors such as aging demographics, lifestyle changes, and the rising incidence of chronic diseases such as diabetes and hypertension. As the population ages, the demand for urology devices for conditions such as urinary incontinence, BPH, and kidney stones is expected to rise.
Advancements in urological procedures and minimally invasive surgical techniques have also fueled market growth by expanding the scope of treatment options available to patients. Urology devices such as catheters, stents, lithotripters, and robotic surgical systems enable healthcare providers to perform complex procedures with greater precision, reduced recovery times, and improved patient outcomes.
Moreover, the increasing awareness of urological health and the availability of advanced diagnostic and treatment options have led to greater patient demand for urology devices and services. As healthcare systems prioritize preventive care and early intervention, the Urology Devices Market is expected to continue growing, offering opportunities for innovation and investment in medical device technology.
The Urology Devices Market is witnessing steady growth, driven by rising urological disorders and technological advancements in medical devices. Urology devices such as catheters, stents, and endoscopes are vital in diagnosing and treating urinary tract conditions. With a growing aging population and increasing awareness, the demand for urology devices continues to escalate.
The urological devices market was valued at USD 36.5 billion in 2022 and is expected to rise from USD 37.96 billion in 2023 to USD 48.5 billion by 2032, with a compound annual growth rate (CAGR) of 4% between 2023 and 2032.
Market Segmentation –
The global Urology Devices market has been segmented based on Type, Application, Technology and End-User.
On the basis of Type, the market is segmented into dialysis equipment, urinary stone treatment devices, endoscopy devices, benign prostatic hyperplasia treatment devices, and urinary incontinence & pelvic organ prolapse. The market revenue for urology devices was dominated by endoscopic devices in 2022, which can be ascribed to the rising prevalence of urolithiasis and the strong demand for disposable cystoscopes, particularly in developed nations.
Based on Application, the global Urology Devices market has been segmented into Minimally Invasive Surgery and Robotic Surgery. In 2022, the minimally invasive surgery category dominated the industry. According to projections, the terminal side segment will experience the largest growth between 2023 and 2030, with an increase in urological problem patients choosing minimally invasive procedures over more invasive ones.
Based on Technology, the global Urology Devices market has been segmented into benign prostatic hyperplasia, prostate cancer, urinary stones, and urinary incontinence. Due to the higher risk of developing urine incontinence in diabetic patients, the urinary incontinence Urology Devices category had the majority share of the market revenue for Urology Devices in 2022.
Based on End-User, the global Urology Devices market has been segmented into hospitals and ambulatory services. Due to the increasing number of patient visits at hospitals for urology-related illnesses, the hospitals and clinics segment, which held the market's top spot in 2022, is anticipated to grow at the fastest rate throughout the forecast period, 2023-2030.
Regional Analysis –
The regional analysis of the urology devices market reveals varying dynamics influenced by factors such as healthcare infrastructure development, prevalence of urological disorders, and regulatory frameworks. North America dominates the market, driven by the high prevalence of conditions like urinary incontinence and kidney stones, coupled with advanced medical technology adoption. Europe follows suit, with increasing investments in urology devices and rising demand for minimally invasive procedures. In the Asia-Pacific region, improving access to healthcare services, growing aging population, and increasing awareness about urological health contribute to market growth. Developing regions in Latin America and Africa are also witnessing gradual market expansion as healthcare infrastructure improves and awareness about urological disorders increases.
Key Players –
Urology devices companies include KARL STORZ GmbH & Co. KG, Olympus Corporation, Medtronic, Boston Scientific Corporation, R. Bard, Fresenius Medical Care AG & Co. KGaA (Germany), Dornier MedTech (Germany), and Stryker (US)
Related Reports –
US Melanoma
Middle East and Africa HIV Diagnosis & Treatment
Gastroparesis Treatment
Dental Infection Treatment
For more information visit at MarketResearchFuture
#Urology Devices Market#Urology Devices Market Size#Urology Devices Market Share#Urology Devices Market Trends#Urology Devices Market Growth
0 notes
Text
Transforming Therapeutics: Market Trends and Forecasts for Drug-Device Combinations
The global drug device combination products market size is expected to reach USD 251.87 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive techniques due to enhanced patient outcomes associated with it is the high impact-rendering driver of this market. These devices facilitate early diagnosis and reduce treatment duration in a majority of surgical procedures. Growing demand is also a consequence of minimal pain, heightened cost efficiency, improved safety, better efficacy, rapid recovery, and reduced hospital stay rendered by these devices.
Increasing presence of regulatory healthcare authorities enforcing clearly defined protocols for premarket authorizations is anticipated to support manufacturers in gaining approvals for their products. Recently, the U.S. FDA incorporated the lean management process mapping approach to build a more cohesive, streamlined, systematic, and collaborative system for the review of the aforementioned products. Safety guidelines and recommendations issued by these authorities are presumed to increase the adoption of these products in future and boost overall growth during the forecast period.
Severe side effects and drug interactions associated with therapeutics owing to drug absorption by unintended sites in the body are anticipated to induce need for targeted therapy, thereby propelling demand for drug-device combinations. For instance, consistent administration of Levodopa results in long-term complications such as motor fluctuations, dyskinesias, severe metabolic changes, and neurotoxic effects. These aforementioned factors drive the clinical urgency to incorporate alternatives based on targeted therapy, as in case of drug-device combination products.
Drug Device Combination Products Market Report Highlights
Transdermal patch held the dominant share by product in 2023 owing to increasing demand for self-administration of drugs in diseases requiring long-term treatment
North America held the largest share of over 41.31% in 2023 in terms of region owing to extensive new product development activities conducted by prominent players across this region
Asia Pacific is anticipated to grow at a lucrative rate over the coming years owing to increasing healthcare spending and rising awareness levels of physicians pertaining to benefits of these products
Key market players are engaged in various strategies such as new product launch and distribution agreements to gain market penetration
High operational cost, stringent regulatory framework, and capital requirement keep entry barriers at a higher level, owing to which, threat of new entrants is expected to be low.
Drug Device Combination Products Market Segmentation
Grand View Research has segmented the global drug device combination products market based on product and region:
Drug Device Combination Product Outlook (Revenue, USD Billion, 2018 - 2030)
Infusion Pumps
Volumetric
Disposables
Syringes
Ambulatory
Implantable
Insulin
Orthopedic Combination Products
Bone Graft Implants
Antibiotic Bone Cement
Photodynamic Therapy Devices
Transdermal Patches
Drug Eluting Stents
Coronary Stents
Peripheral Vascular Stents
Wound Care Products
Inhalers
Dry Powder
Nebulizers
Metered Dose
Antimicrobial Catheters
Urological
Cardiovascular
Others
Others
Drug Device Combination Products Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
US
Canada
Europe
Germany
UK
France
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players
Abbott
Terumo Medical Corporation
Stryker
Viatris Inc.
Medtronic
Boston Scientific Corporation
Novartis AG
Becton, Dickinson and Company.
Teleflex Incorporated
L. Gore & Associates, Inc. Sensely, Inc.
Order a free sample PDF of the Drug Device Combination Products Market Intelligence Study, published by Grand View Research.
0 notes
Text
Nephrostomy Balloon Catheter Market, Global Outlook and Forecast 2025-2032
Nephrostomy Balloon Catheters are specialized medical devices used during percutaneous renal procedures to dilate the muscles, fascia, and renal capsule, creating a tract between the skin and kidney. This tract facilitates access for further procedures such as stone removal or drainage of the kidney. These catheters play a critical role in urological surgeries, ensuring precision and minimizing patient discomfort during interventions.
Market Size
Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/8027948/global-nephrostomy-balloon-catheter-forecast-2025-2032-115
The global Nephrostomy Balloon Catheter market size was valued at USD 79 million in 2024 and is projected to grow to USD 108.95 million by 2032, reflecting a compound annual growth rate (CAGR) of 4.10% during the forecast period.
North America accounted for a significant share, with its market size estimated at USD 22.06 million in 2024, growing at a CAGR of 3.51% between 2025 and 2032.
The increasing prevalence of kidney-related ailments, coupled with advancements in minimally invasive surgical techniques, is driving market growth. Additionally, the aging population and rising awareness about urological health are further contributing to the market's expansion.
Market Dynamics (Drivers, Restraints, Opportunities, and Challenges)
Drivers
Rising Incidence of Kidney Diseases: The growing prevalence of kidney stones, renal infections, and other urological conditions necessitates the use of nephrostomy balloon catheters.
Advancements in Medical Technology: Innovations in catheter design and materials enhance their efficacy and patient safety, fueling demand.
Increase in Minimally Invasive Procedures: The shift towards minimally invasive surgeries is boosting the adoption of these specialized devices.
Growing Geriatric Population: As the elderly population grows, the need for urological interventions increases, driving the market forward.
Rising Incidence of Kidney Diseases: The growing prevalence of kidney stones, renal infections, and other urological conditions necessitates the use of nephrostomy balloon catheters.
Advancements in Medical Technology: Innovations in catheter design and materials enhance their efficacy and patient safety, fueling demand.
Increase in Minimally Invasive Procedures: The shift towards minimally invasive surgeries is boosting the adoption of these specialized devices.
Growing Geriatric Population: As the elderly population grows, the need for urological interventions increases, driving the market forward.
Restraints
High Cost of Procedures: The high cost associated with percutaneous renal surgeries may limit adoption in low-income regions.
Limited Awareness in Developing Countries: Inadequate awareness and access to advanced healthcare facilities in emerging markets could hinder growth.
High Cost of Procedures: The high cost associated with percutaneous renal surgeries may limit adoption in low-income regions.
Limited Awareness in Developing Countries: Inadequate awareness and access to advanced healthcare facilities in emerging markets could hinder growth.
Opportunities
Untapped Markets in Emerging Economies: Developing countries present significant growth opportunities due to increasing healthcare infrastructure and rising awareness.
Focus on R&D: Continued investments in research and development can lead to innovative products with improved performance and cost-effectiveness.
Strategic Collaborations: Partnerships between manufacturers and healthcare providers can help expand market reach and adoption.
Untapped Markets in Emerging Economies: Developing countries present significant growth opportunities due to increasing healthcare infrastructure and rising awareness.
Focus on R&D: Continued investments in research and development can lead to innovative products with improved performance and cost-effectiveness.
Strategic Collaborations: Partnerships between manufacturers and healthcare providers can help expand market reach and adoption.
Challenges
Regulatory Hurdles: Stringent regulatory requirements for medical devices can delay product launches.
Risk of Complications: Potential complications, such as infections or device malfunctions, may pose challenges to market acceptance.
Regulatory Hurdles: Stringent regulatory requirements for medical devices can delay product launches.
Risk of Complications: Potential complications, such as infections or device malfunctions, may pose challenges to market acceptance.
Regional Analysis
North America
North America dominates the Nephrostomy Balloon Catheter market, accounting for a substantial share due to the high prevalence of kidney-related diseases, advanced healthcare infrastructure, and a strong focus on minimally invasive procedures. The market in this region is projected to grow steadily, driven by technological advancements and favorable reimbursement policies.
Europe
Europe holds the second-largest market share, with countries like Germany, the UK, and France leading the region. The growth is attributed to the rising geriatric population, increased healthcare spending, and the adoption of innovative surgical techniques.
Asia-Pacific
The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Factors such as increasing healthcare awareness, rising disposable incomes, and expanding medical infrastructure in countries like China, India, and Japan contribute to this growth.
South America
South America’s market is gradually expanding due to improving healthcare facilities and increasing awareness of advanced medical devices. However, economic constraints may limit rapid growth in this region.
Middle East and Africa
The Middle East and Africa are emerging markets with significant potential. The growth in these regions is driven by improving healthcare infrastructure and increased government initiatives to enhance access to advanced medical technologies.
Competitor Analysis
The competitive landscape of the global Nephrostomy Balloon Catheter market is characterized by the presence of several key players who are focused on innovation, strategic partnerships, and geographic expansion. Leading companies include:
Boston Scientific
Coloplast
BD (Becton, Dickinson and Company)
B. Braun
Amecath Medical Technologies
Cook Medical
GHC German Health Care
Blueneem Medical Devices
Envaste
Urovision-Urotech
Teleflex
Boston Scientific
Coloplast
BD (Becton, Dickinson and Company)
B. Braun
Amecath Medical Technologies
Cook Medical
GHC German Health Care
Blueneem Medical Devices
Envaste
Urovision-Urotech
Teleflex
These companies are investing in research and development to introduce advanced products that cater to evolving patient needs and comply with regulatory standards.
Market Segmentation (by Application)
Hospitals
Hospitals account for the largest application segment due to the high volume of surgeries performed and the availability of advanced medical facilities. The preference for hospital-based procedures is driven by the need for specialized care and post-operative monitoring.
Clinics
Clinics represent a growing segment as more patients seek minimally invasive treatments in outpatient settings. The convenience and cost-effectiveness of clinic-based procedures contribute to their increasing popularity.
Other
This segment includes ambulatory surgical centers and home healthcare settings. The adoption of nephrostomy balloon catheters in these settings is gradually increasing due to advancements in portable medical devices.
Market Segmentation (by Type)
Balloon Length 12cm
This type is widely used for its compatibility with standard procedures and ease of use. Its demand is driven by its effectiveness in creating a precise tract during renal surgeries.
Balloon Length 15cm
The longer balloon length is preferred for specific cases requiring extended dilation. Its specialized application makes it a vital segment in the market.
Other
This category includes custom lengths and specialized designs tailored for unique medical needs.
Key Company
The market’s leading players are focused on innovation and strategic initiatives to maintain their competitive edge. These companies include:
Boston Scientific
Coloplast
BD
B. Braun
Amecath Medical Technologies
Cook Medical
GHC German Health Care
Blueneem Medical Devices
Envaste
Urovision-Urotech
Teleflex
Boston Scientific
Coloplast
BD
B. Braun
Amecath Medical Technologies
Cook Medical
GHC German Health Care
Blueneem Medical Devices
Envaste
Urovision-Urotech
Teleflex
Geographic Segmentation
North America: USA, Canada, Mexico
Europe: Germany, UK, France, Russia, Italy, Rest of Europe
Asia-Pacific: China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific
South America: Brazil, Argentina, Columbia, Rest of South America
Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA
North America: USA, Canada, Mexico
Europe: Germany, UK, France, Russia, Italy, Rest of Europe
Asia-Pacific: China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific
South America: Brazil, Argentina, Columbia, Rest of South America
Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA
FAQ Section
What is the current market size of the Nephrostomy Balloon Catheter market?
The global market size was estimated at USD 79 million in 2024 and is projected to reach USD 113.42 million by 2032, growing at a CAGR of 4.10%.
Which are the key companies operating in the Nephrostomy Balloon Catheter market?
Major players include Boston Scientific, Coloplast, BD, B. Braun, Amecath Medical Technologies, Cook Medical, and Teleflex.
What are the key growth drivers in the Nephrostomy Balloon Catheter market?
Key drivers include the rising prevalence of kidney diseases, advancements in medical technology, and the growing demand for minimally invasive procedures.
Which regions dominate the Nephrostomy Balloon Catheter market?
North America leads the market, followed by Europe and the Asia-Pacific region.
What are the emerging trends in the Nephrostomy Balloon Catheter market?
Emerging trends include the development of advanced balloon catheter designs, increasing focus on R&D, and expanding applications in outpatient and home healthcare settings.
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nephrostomy Balloon Catheter Market
Overview of the regional outlook of the Nephrostomy Balloon Catheter Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
Get the Complete Report & TOC @ https://www.statsmarketresearch.com/global-nephrostomy-balloon-catheter-forecast-2025-2032-115-8027948
Table of content
Table of Contents 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Nephrostomy Balloon Catheter 1.2 Key Market Segments 1.2.1 Nephrostomy Balloon Catheter Segment by Type 1.2.2 Nephrostomy Balloon Catheter Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Nephrostomy Balloon Catheter Market Overview 2.1 Global Market Overview 2.1.1 Global Nephrostomy Balloon Catheter Market Size (M USD) Estimates and Forecasts (2019-2032) 2.1.2 Global Nephrostomy Balloon Catheter Sales Estimates and Forecasts (2019-2032) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Nephrostomy Balloon Catheter Market Competitive Landscape 3.1 Global Nephrostomy Balloon Catheter Sales by Manufacturers (2019-2025) 3.2 Global Nephrostomy Balloon Catheter Revenue Market Share by Manufacturers (2019-2025) 3.3 Nephrostomy Balloon Catheter Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Nephrostomy Balloon Catheter Average Price by Manufacturers (2019-2025) 3.5 Manufacturers Nephrostomy Balloon Catheter Sales Sites, Area Served, Product Type 3.6 Nephrostomy Balloon Catheter Market Competitive Situation and Trends 3.6.1 Nephrostomy Balloon Catheter Market Concentration Rate 3.6.2 Global 5 and 10 Largest Nephrostomy Balloon Catheter Players Market Share by Revenue 3.6.
Customize/Section/Part Purchase @ https://www.statsmarketresearch.com/chapters-purchase/8027948/global-nephrostomy-balloon-catheter-forecast-2025-2032-115
Check other links >>> https://www.linkedin.com/feed/update/urn:li:activity:7287335391135748096 https://www.linkedin.com/feed/update/urn:li:activity:7287344578616025088 https://www.linkedin.com/feed/update/urn:li:activity:7287358160481247233 https://www.linkedin.com/feed/update/urn:li:activity:7287368888298692608 https://www.linkedin.com/feed/update/urn:li:activity:7287391921906343936
0 notes
Text
Endoscopy devices market is positioned for sustained growth, driven by the increasing demand for minimally invasive diagnostic and therapeutic procedures
Market Overview
The global endoscopy devices market is projected to reach a size of USD 40.10 billion in 2025 and is expected to grow to USD 55.09 billion by 2030, advancing at a compound annual growth rate (CAGR) of 6.56% during the forecast period from 2025 to 2030. Endoscopy refers to a medical procedure that involves the use of an endoscope to visually examine the internal organs or cavities of the body. These devices are commonly used in procedures involving the gastrointestinal tract, respiratory system, urinary tract, and other internal structures. Endoscopy has become an essential part of modern diagnostics and treatment, offering advantages such as minimal invasiveness, faster recovery times, and reduced risk of complications.
The endoscopy devices market includes various products, such as rigid and flexible endoscopes, robotic-assisted endoscopy systems, video processors, and endoscopic instruments. These devices are widely used in both diagnostic and therapeutic procedures, with applications in gastroenterology, pulmonology, urology, orthopedics, and other specialties.
Key Market Drivers
Rising Prevalence of Chronic Diseases The increasing prevalence of chronic diseases such as gastrointestinal disorders, cancers, respiratory diseases, and urological conditions has led to higher demand for endoscopic procedures. Conditions like colorectal cancer, which requires early detection for effective treatment, have driven the growth of the endoscopy market as a preferred method for diagnosis and monitoring.
Growing Preference for Minimally Invasive Surgeries Minimally invasive procedures, including endoscopy, are increasingly preferred due to their ability to reduce recovery time, minimize surgical risks, and ensure faster patient recovery. The growing demand for such procedures in both diagnostic and therapeutic applications has positively impacted the endoscopy devices market.
Technological Advancements Ongoing technological advancements in the field of endoscopy are enhancing the capabilities and functionality of endoscopic devices. Innovations like high-definition video imaging, 3D visualization, robotic-assisted surgery, and integration with Artificial Intelligence (AI) are improving the precision, accuracy, and overall efficiency of endoscopy procedures. The adoption of these innovations is further boosting market growth.
Aging Population The global population is rapidly aging, with an increasing number of people requiring healthcare services. The elderly are more susceptible to a range of chronic conditions, particularly gastrointestinal and respiratory diseases, which necessitate frequent diagnostic and therapeutic interventions. This demographic shift is driving the demand for endoscopy devices across the globe.
Rising Demand for Early Disease Detection Early detection of diseases plays a significant role in improving patient outcomes and reducing healthcare costs. Endoscopic procedures allow for early detection and diagnosis of conditions such as cancer, gastrointestinal disorders, and respiratory diseases, thereby encouraging the adoption of endoscopy devices.
Market Segmentation
By Product Type
Rigid Endoscopes: These are typically used for procedures in areas such as orthopedics, urology, and gynecology, where minimal flexibility is required.
Flexible Endoscopes: These devices are more commonly used in procedures involving the gastrointestinal and respiratory systems due to their ability to navigate complex anatomical pathways.
Capsule Endoscopes: Small, ingestible devices used primarily for examining the gastrointestinal tract, especially in cases of gastrointestinal bleeding or Crohn’s disease.
Robot-Assisted Endoscopes: These devices are used in robotic surgery systems and provide increased precision and control during complex surgeries.
By Application
Gastrointestinal Endoscopy: This is one of the largest segments, driven by the prevalence of conditions like colorectal cancer, gastroesophageal reflux disease (GERD), and irritable bowel syndrome (IBS).
Pulmonary Endoscopy: Used for the examination and diagnosis of respiratory diseases like chronic obstructive pulmonary disease (COPD), lung cancer, and asthma.
Urological Endoscopy: Involves procedures to diagnose and treat urological conditions such as kidney stones, bladder cancer, and prostate disorders.
Orthopedic Endoscopy: Used for diagnosing and treating musculoskeletal conditions, including joint issues and sports injuries.
Other Applications: Including gynecology, neurology, and ENT (Ear, Nose, and Throat) procedures.
By End-User
Hospitals: Hospitals remain the largest end-user of endoscopy devices, given the prevalence of surgical procedures and diagnostic testing.
Ambulatory Surgical Centers (ASCs): Increasingly popular for performing outpatient procedures, ASCs are adopting endoscopy devices due to their minimally invasive nature and cost-effectiveness.
Specialty Clinics: Specialized centers such as gastroenterology, urology, and pulmonology clinics also contribute significantly to the demand for endoscopic devices.
Others: Including diagnostic laboratories and research institutes.
By Geography
North America: The North American market holds a significant share due to the high adoption of advanced technologies, a well-established healthcare infrastructure, and a large elderly population. The U.S. is a leader in the endoscopy devices market, driven by extensive healthcare spending.
Europe: Europe is also a prominent region for endoscopy devices, with key players and a high incidence of chronic diseases like cancer and gastrointestinal disorders.
Asia Pacific: The Asia Pacific region is expected to witness the highest growth rate due to factors such as increasing healthcare investments, a growing aging population, and expanding access to healthcare in emerging economies like China and India.
Latin America & Middle East & Africa: These regions are gradually adopting endoscopic procedures, with increasing healthcare investments and the expansion of healthcare infrastructure.
Market Challenges
High Cost of Endoscopic Equipment Endoscopic devices, especially advanced models like robotic-assisted systems and high-definition video scopes, can be expensive. The high initial investment required for such equipment may be a challenge for smaller healthcare facilities and developing economies. Although the long-term cost savings of minimally invasive procedures may offset these initial costs, the price remains a significant barrier to adoption in certain regions.
Lack of Skilled Professionals Performing endoscopic procedures requires specialized training and expertise. The shortage of skilled healthcare professionals capable of operating endoscopy equipment poses a challenge, particularly in emerging markets. This issue can impact the efficacy and safety of endoscopic procedures, limiting the growth potential of the market in some regions.
Risk of Infection and Complications Although endoscopy is considered a minimally invasive procedure, there is still a risk of infection and other complications, such as bleeding or perforation. These risks require proper training, sterilization protocols, and equipment maintenance to ensure patient safety.
Future Outlook and Opportunities
The endoscopy devices market is expected to experience robust growth over the coming years, driven by ongoing technological innovations and the increasing demand for minimally invasive procedures. Some key opportunities include:
Integration of Artificial Intelligence (AI) The integration of AI in endoscopy devices is a major trend that is set to transform the market. AI-powered endoscopy systems can provide real-time image analysis, assist in diagnosing conditions, and even predict patient outcomes. These systems are poised to improve the accuracy and efficiency of endoscopic procedures.
Point-of-Care (POC) Devices The development of portable, point-of-care endoscopy devices presents significant growth opportunities. These devices can be used in various settings, such as outpatient clinics and rural areas, where access to specialized healthcare facilities is limited.
Minimally Invasive Surgical Robotic Systems As robotic-assisted surgery becomes more widespread, the demand for robotic endoscopy devices is set to grow. These systems offer higher precision, reduce human error, and allow for better patient outcomes, making them increasingly popular in complex surgeries.
Conclusion
The endoscopy devices market is positioned for sustained growth, driven by the increasing demand for minimally invasive diagnostic and therapeutic procedures, technological advancements, and the growing global burden of chronic diseases. While challenges such as high costs and the need for skilled professionals remain, the market offers numerous opportunities, particularly in AI integration, robotic surgery, and point-of-care applications. As innovation continues to shape the landscape, endoscopy devices will remain an integral part of modern healthcare, improving patient outcomes and driving the future of medical diagnostics and treatment.
For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence
0 notes
Text
0 notes
Text
Urology Devices Market in terms of revenue was estimated to be worth $34.1 billion in 2023 and is poised to reach $48.6 billion by 2028, growing at a CAGR of 7.3% from 2023 to 2028 according to a new report by MarketsandMarkets. The high prevalence of urological diseases significantly impacts the increased demand for urological devices. Cancer patients who need surgical interventions with latest technologies like minimally invasive surgery and robotic surgeries. This will lead to an increased need for urological devices. Thus, the escalating demand for urological disease diagnosis and treatment, has led to a pressing need for technologically advanced devices, which is thereby expected to support the growth of the urological devices market.
#Global Urology Devices Market#Urology Devices Industry#Urology Devices Market Size#Urology Devices Market Growth#Urology Devices Market Outlook
0 notes
Text
Introduction to Ablation Systems: Overview and Applications
The global ablation systems market size was USD 5.75 Billion in 2022 and is expected to register a rapid revenue CAGR of 8.6% during the forecast period. Increasing integration of ablation systems with imaging technologies and rising adoption of robotics and navigation technologies are major factors driving market revenue growth.
Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/2557
Competitive Terrain:
The global Ablation Systems industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
The leading market contenders listed in the report are:
Medtronic, Johnson & Johnson, Abbott, Boston Scientific Corporation, AngioDynamic, Olympus, Smith+Nephew, Stryker, Dornier MedTech, and Cynosure, LLC
Key market aspects studied in the report:
Market Scope: The report explains the scope of various commercial possibilities in the global Ablation Systems market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Competitive Outlook: The leading companies operating in the Ablation Systems market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.
Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Ablation Systems market.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/2557
Market Segmentations of the Ablation Systems Market
This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Ablation Systems market on the basis of product, application, and region:
Segments Covered in this report are:
Device Technology Outlook (Revenue, USD Billion; 2019-2032)
Radiofrequency (RF) Devices
Ultrasound Devices
Others
Application Outlook (Revenue, USD Billion; 2019-2032)
Cancer Treatment
Ophthalmologic Treatment
Urological Treatment
Others
End-Use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals & Clinics
Ambulatory Surgical Centers (ASCs)
Others
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/ablation-systems-market
Major Geographies Analyzed in the Report:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
ToC of the report:
Chapter 1: Market overview and scope
Chapter 2: Market outlook
Chapter 3: Impact analysis of COVID-19 pandemic
Chapter 4: Competitive Landscape
Chapter 5: Drivers, Constraints, Opportunities, Limitations
Chapter 6: Key manufacturers of the industry
Chapter 7: Regional analysis
Chapter 8: Market segmentation based on type applications
Chapter 9: Current and Future Trends
Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/2557
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Trending Titles: Geocell Market | Pancreatic Cancer Treatment Market
Latest Report: Ceramic Tiles Market | Life Science Analytics Market
0 notes
Text
0 notes
Text
Saudi Arabia Medical Lasers Market Analysis 2030
Saudi Arabia Medical Lasers Market was valued at USD 100.2 million in 2022 and is expected to reach USD 236.6 million in 2030 with a CAGR of 11.34% for the forecast period between 2023 and 2030. The medical lasers market in Saudi Arabia has been experiencing significant growth and technological advancements. Medical lasers are specialized devices used in various medical procedures to perform precise and minimally invasive treatments, making them a sought-after technology in the healthcare industry. The increasing prevalence of chronic diseases, rising demand for non-invasive treatment options, and a growing healthcare infrastructure have been major drivers for the medical lasers market in Saudi Arabia.
Moreover, the country’s aging population has further fueled the need for advanced medical technologies like lasers. Saudi Arabia’s government has been actively investing in the healthcare sector, supporting the adoption of innovative medical technologies such as medical lasers. This commitment has facilitated the introduction of state-of-the-art laser systems in hospitals and clinics nationwide.
The increasing range of medical applications of lasers has also driven the market. Medical professionals increasingly use lasers in dermatology for skin treatments, in ophthalmology for vision correction surgeries, in dentistry for various oral procedures, and in oncology for cancer treatments. Advancements in laser technology have improved their efficiency, safety, and versatility. Laser systems with better precision and reduced side effects have garnered the attention of healthcare providers and patients alike. As the demand for minimally invasive treatment options continues to rise, the market is expected to expand further, providing better healthcare outcomes for patients in the region.
Increasing Demand for Aesthetic Procedures
There has been a significant increase in the demand for aesthetics-related medical laser treatments in Saudi Arabia. Aesthetic procedures utilizing medical lasers, such as laser hair removal, skin rejuvenation, tattoo removal, and body contouring, have gained popularity among men and women seeking non-invasive cosmetic enhancements. The rise in demand can be attributed to several factors. First, there is a growing awareness of aesthetic procedures and their positive impact on self-confidence and appearance. Second, the cultural shift towards accepting cosmetic enhancements to maintain youthful looks has increased interest in medical laser treatments. Advancements in laser technology have led to safer, more effective, and less painful aesthetic procedures, reducing the associated downtime. Additionally, specialized aesthetic clinics and well-trained healthcare professionals offering these services have played a crucial role in meeting the rising demand.
During February 2020, Sisram Medical Ltd (Alma Lasers) introduced ClearSkin PRO, an innovative applicator with twice the power of its predecessors, providing noticeable improvements in the appearance of skin, leading to a more youthful look.
Progress in the field of Urology
Saudi Arabia has witnessed significant progress and advancements, particularly in applying medical lasers to the field of Urology. The Saudi Arabia medical laser market has experienced notable growth as cutting-edge laser technologies are increasingly adopted in urological procedures. Medical lasers have revolutionized urological treatments by offering minimally invasive solutions for various conditions, such as kidney stones, benign prostatic hyperplasia (BPH), and urological cancers. The precise and targeted nature of laser technology has led to reduced complications, shorter recovery times, and improved patient outcomes. The Saudi Arabian healthcare system’s commitment to investing in advanced medical technologies has facilitated the integration of lasers into urological practice. This progress has been supported by collaborations between healthcare institutions and medical device manufacturers, leading to the continuous refinement and development of laser-based urological treatments.
In July 2021, Lumenis introduced a comprehensive worldwide education platform, MOSES HoLEP University. This platform enables urologists to offer patients state-of-the-art treatment for benign prostatic hyperplasia (BPH) called formium laser enucleation (HoLEP) of the prostate using the innovative MOSES technology. The MOSES HoLEP University equips urologists with the necessary knowledge and skills to perform this advanced procedure, which has been established as the gold standard for treating BPH.
Surge in Surgical Interventions
The Saudi Arabia medical lasers market has witnessed a notable increase in surgical procedures. This upsurge can be attributed to several factors driving the demand for medical lasers in the country. Firstly, a growing population with rising healthcare needs has increased the prevalence of chronic diseases and age-related conditions, necessitating more surgical interventions. Advancements in medical technology and innovative surgical techniques have bolstered the confidence of healthcare practitioners and patients, leading to a greater willingness to opt for surgical treatments.
Additionally, the government’s efforts to improve healthcare infrastructure and increase access to medical facilities across the country have contributed to the rise in surgical procedures. The growing awareness among the population regarding the availability and benefits of modern medical devices has fuelled the demand for such procedures. As the healthcare sector in Saudi Arabia continues to evolve and cater to the increasing healthcare demands, the trend of rising surgical procedures is expected to persist in the foreseeable future.
Technological Advancements
Saudi Arabia has witnessed remarkable technological advancement in the Medical Lasers market. Innovations in laser technology have revolutionized medical procedures, offering precise and minimally invasive solutions for various healthcare applications. One significant area of advancement is in the field of dermatology and aesthetics. Advanced medical lasers have enabled the treatment of skin conditions, such as acne, pigmentation, and scars, with higher precision and reduced downtime. Moreover, introducing fractional lasers has allowed safer and more effective skin resurfacing procedures. In addition to dermatology, medical lasers have also transformed surgical practices. Laser-assisted surgeries have gained popularity because they provide better tissue targeting, reduced bleeding, and faster recovery times. Medical lasers have become integral to various specialties from ophthalmology to gynecology and urology. Advancements in laser technology have also expanded into the realm of non-invasive treatments for chronic pain management and physical therapy. Low-level laser therapy has shown promising results in accelerating tissue repair and reducing inflammation.
In Saudi Arabia, Imdad provides a range of products, including Lutronic’s eCO2 plus, a fractional ablative CO2 laser designed for scar and laxity improvement. It utilizes a 120 µ tip to achieve deep fractional ablation. Additionally, Candela Medical offers Picoway, a pico-second laser with a pulse duration of 450 PS, making it ideal for skin resurfacing.
Impact of COVID-19
The COVID-19 pandemic has significantly impacted the Saudi Arabia medical lasers market. While initial disruption was due to lockdowns and reduced elective procedures, the market gradually recovered with the resumption of healthcare services. The increased adoption of telemedicine and remote consultations during the pandemic led to a surge in demand for laser-based treatments that can be administered with minimal contact. The growing focus on hygiene and infection control measures also bolstered the preference for laser procedures over traditional methods.
Following the severe impact of COVID-19 on the market, a noticeable shift occurred post-2021, with the pandemic under control. This shift was characterized by an increasing trend in aesthetic procedures, driven by a heightened emphasis on appearance among the general population. According to a research study conducted by Abdulaziz K. Alhujayri et al. and published in Plastic and Reconstructive Surgery Global Open Journal in June 2021, there were great disparities in the engagement and perception of cosmetic procedures among the Saudi Arabian population during the COVID-19 pandemic. The study revealed that approximately 49.7% of the population cited fear of contracting the virus as a significant factor that deterred them from undergoing cosmetic procedures throughout the pandemic.
Download Free Sample Report
Saudi Arabia Medical Lasers Market: Report Scope
Saudi Arabia Medical Lasers Market Assessment, Opportunities and Forecast, 2016-2030”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative & and quantitative assessment of the current state of the Medical Lasers market, industry dynamics and challenges. The report includes market size, segmental shares, growth trends, COVID-19, opportunities, and forecasts between 2023 and 2030F. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.
Click here for full report- https://www.marketsandata.com/industry-reports/saudi-arabia-medical-lasers-market
Latest reports-
Contact
Mr. Vivek Gupta 5741 Cleveland street, Suite 120, VA beach, VA, USA 23462 Tel: +1 (757) 343–3258 Email: [email protected] Website: https://www.marketsandata.com
0 notes
Text
Global Laparoscopy Devices Market Report: Insights, Trends, and Key Players
Straits Research, a leading provider of business intelligence, is pleased to announce the release of its latest report on the global Laparoscopy Devices Market. This comprehensive report provides valuable insights into market size, growth drivers, key developments, and major players, offering essential information for stakeholders and industry participants.
Request a Sample Report of Laparoscopy Devices Market
Market Size
The global Laparoscopy Devices Market was valued at USD 27.17 billion in 2024 and is projected to grow significantly, reaching USD 49.95 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 7% during the forecast period from 2025 to 2033. The increasing adoption of minimally invasive surgical procedures and advancements in laparoscopic technologies are key factors driving this market expansion.
Drivers in the Laparoscopy Devices Market
Several factors are contributing to the growth of the Laparoscopy Devices Market:
• Rising Demand for Minimally Invasive Surgeries: Patients and healthcare providers are increasingly opting for minimally invasive procedures due to their benefits, such as reduced recovery time, lower risk of complications, and shorter hospital stays. • Technological Advancements: Continuous innovations in laparoscopic devices, including high-definition imaging systems, robotic-assisted surgery systems, and advanced energy devices, are enhancing the efficiency and outcomes of laparoscopic surgeries. • Growing Prevalence of Chronic Diseases: The increasing incidence of chronic conditions, such as obesity, colorectal cancer, and gynecological disorders, is driving the demand for laparoscopic interventions. • Favorable Reimbursement Policies: Supportive reimbursement frameworks in various regions are encouraging the adoption of laparoscopic procedures.
Key Developments in the Laparoscopy Devices Market
The Laparoscopy Devices Market is witnessing several key developments:
• Integration of Artificial Intelligence (AI): AI-powered laparoscopic systems are being developed to assist surgeons in decision-making, improving precision and reducing the risk of errors. • Enhanced Imaging Technologies: The introduction of 4K and 3D imaging systems is providing surgeons with clearer and more detailed views during procedures, leading to better surgical outcomes. • Robotic-Assisted Surgery: The adoption of robotic-assisted laparoscopic systems is increasing, offering greater dexterity and control to surgeons, especially in complex procedures. • Sustainability Initiatives: Companies are focusing on developing eco-friendly laparoscopic devices and packaging to reduce environmental impact.
Request a Sample Report of Laparoscopy Devices Market
Top Key Players
The Laparoscopy Devices Market is highly competitive, with several key players leading the industry:
1.B. Braun Melsungen AG 2.ConMed Corporation 3.Boston Scientific Corporation 4.Johnson and Johnson 5.Medtronic Plc. (Covidien) 6.Karl Storz SE and CO. KG 7.Richard Wolf GmbH 8.Olympus Corporation 9.Stryker Corporation
These companies are at the forefront of the Laparoscopy Devices Market, offering a wide range of innovative products and solutions to meet the growing demand for laparoscopic procedures.
Segmentation Analysis of the Laparoscopy Devices Market
The market is segmented based on product type, applications, and end-user:
By Product Type: • Laparoscopes • Energy Devices • Insufflators • Robot-Assisted Surgery Systems • Suction or Irrigation Systems • Closure Devices • Hand Instruments • Access Devices • Accessories • Others
By Applications: • General Surgery • Bariatric Surgery • Gynecological Surgery • Urological Surgery • Colorectal Surgery • Others
By End-User: • Hospitals • Clinics • Others
Buy Laparoscopy Devices Market Report here!
About Straits Research
Straits Research is a top provider of business intelligence, specializing in research, analytics, and advisory services. We focus on delivering in-depth insights through comprehensive reports, helping businesses make informed decisions and achieve sustainable growth.
Contact Us:
Email: [email protected] Address: 825 3rd Avenue, New York, NY, USA, 10022 Phone: +1 646 905 0080 (US), +91 8087085354 (India), +44 203 695 0070 (UK) For more information about the Laparoscopy Devices Market report, please visit our website or contact us directly.
#Laparoscopy Devices Market#Laparoscopy Devices Market Size#Laparoscopy Devices Market Share#Laparoscopy Devices Market Growth#Laparoscopy Devices Market Analysis
0 notes
Text
Saudi Arabia Disposable Endoscopy Market size by value at USD 486.9 million in 2023.During the forecast period between 2024 and 2030, BlueWeave expects Saudi Arabia Disposable Endoscopy Market size to expand at a CAGR of 5.60% reaching a value of USD 716.8 million by 2030. Saudi Arabia Disposable Endoscopy Market is driven by the rising prevalence of gastrointestinal, respiratory, and urological diseases, coupled with the growing demand for minimally invasive procedures. Increasing healthcare investments and the adoption of advanced technologies in hospitals and clinics further boost market growth. Disposable endoscopes reduce cross-contamination risks, aligning with stringent infection control policies. Additionally, the expanding medical tourism sector and an aging population contribute to the increasing demand for efficient, safe, and cost-effective endoscopy solutions.
Sample Request: https://www.blueweaveconsulting.com/report/saudi-arabia-disposable-endoscopy-market/report-sample
Opportunity – Continuous Advancements in Endoscopy Technology
Saudi Arabia Disposable Endoscopy Market is witnessing growth due to continuous technological advancements in endoscopy. Innovations, such as high-definition imaging, improved optical systems, and enhanced disposable endoscopic devices, are addressing infection control challenges while improving diagnostic accuracy. These advancements align with the country's focus on healthcare modernization under Vision 2030. Additionally, the integration of AI and robotics into endoscopy supports minimally invasive procedures, increasing adoption among healthcare providers and driving demand for disposable endoscopy solutions.
#Blueweave#Consulting#marketreserch#marketforecast#DisposableEndoscopyMarket#EndoscopyMarketGrowth#MedicalDeviceMarket#HealthcareInKSA#MedicalInnovation#HealthcareTrends
0 notes
Text
Urology Devices Market worth $48.6 billion by 2028
Urology Devices Market in terms of revenue was estimated to be worth $34.1 billion in 2023 and is poised to reach $48.6 billion by 2028, growing at a CAGR of 7.3% from 2023 to 2028 according to a new report by MarketsandMarkets. The high prevalence of urological diseases significantly impacts the increased demand for urological devices. Cancer patients who need surgical interventions with latest technologies like minimally invasive surgery and robotic surgeries. This will lead to an increased need for urological devices. Thus, the escalating demand for urological disease diagnosis and treatment, has led to a pressing need for technologically advanced devices, which is thereby expected to support the growth of the urological devices market.
Urology Devices Market Trends
Download an Illustrative overview:
Browse in-depth TOC on "Urology Devices Industry"
159 - Tables
44 - Figures
274 – Pages
In 2022, the instruments segment held the largest share of the urology devices market by product segment.
The urology devices market is segmented into instruments and consumables & accessories based on products. The instruments segment accounted for the largest share of the urology devices market in 2022. This segment covers the most commonly used products, such as dialysis devices, endoscopes, laser & lithotripsy devices, endovision & imaging systems, robotic systems, insufflators, endoscopy fluid management systems, urodynamic systems and other instruments. These products are commonly used in hospitals, dialysis centers and home care settings. As technologies continue to evolve, the efficiency and accuracy of these products contribute significantly to the urological procedures.
The kidney diseases segment held the largest share of the urology devices industry by application segment in 2022.
The global urology devices market is differentiated into kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications. In 2022, the kidney diseases segment dominated the urology devices market. The urology devices market in kidney diseases is expected to grow at a high rate owing to the rising incidence of kidney diseases and chronic diseases. With a burgeoning global population, the need for urology devices has significantly increased due to the increased number of procedures required. Hospitals and dialysis centers are at the forefront of this surge, as they cater to routine medical care and handle emergencies.
The hospitals, ASCA & clinics segment held the largest share of the urology devices industry by end-user segment in 2022.
The global urology devices market is differentiated into hospitals, ASCS & clinics, dialysis centers and home care settings. In 2022, the hospitals, ASCS & clinics segment dominated the urology devices market. The urology devices market in hospitals is expected to grow at a high rate owing to the increasing number of surgical procedures related to urology care. The expanding network of healthcare institutions directly translates to a substantial market share, reflecting the pivotal role hospitals play in safeguarding patient well-being.
North America is the largest regional market for urology devices industry.
The market for urology devices has been divided into five key geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the predominant portion of the urology devices market. This can be attributed to the region's advanced healthcare facilities and substantial healthcare investments, which are pivotal in fueling the requirement for urology devices. Moreover, the projected rise in urological procedures is anticipated to contribute to the expansion of the market. As the demand for urological procedures rises, so does the need for precise urological devices to ensure successful and safe procedures.
Request Sample Pages:
Urology Devices Market Dynamics:
Drivers:
Rising incidence of urological diseases
Growing preference for minimally invasive procedures
Rising focus on R&D and product launches
Growing number of hospitals and surgical centers
Restraints:
High degree of consolidation among key players
Opportunities:
Growing Potential growth opportunities in emerging economies
Technological advancements
Challenge:
Increasing number of product recalls by key players
Shortage of skilled urologists
Key Market Players of Urology Devices Industry:
The major players operating in urology devices market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Cardinal Health (US), Olympus Corporation (Japan), Intuitive Surgical (US), Coloplast A/S (Denmark), Stryker Corporation (US), Teleflex Incorporated (US), Convatec Group PLC (UK), Medtronic PLC (Ireland), Karl Storz (Germany), Cook Medical (US), Richard Wolf GmbH (Germany), CompactCath (US), Dornier MedTech (Germany), Nikkiso Co., Ltd. (Japan), Dialife SA (Switzerland), Erbe Vision (Germany), Well Lead Medical Co., Ltd. (China), ROCAMED (Germany), EndoMed Systems GmbH (Germany), Amniso International, Inc. (US), Medispec (US), Medical Technologies of Georgia (US), Vimex Sp. z o.o. (Poland), Balton Sp. z o.o. (Poland), Hunter Urology (UK), Ribbel International Ltd. (India).
Fresenius Medical Care AG & Co. KGaA (Germany) maintained its dominant position in the urology devices market in 2022. The company’s strong distribution networks spanning North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa have contributed to its sustained leadership in the market. The company employs organic and inorganic growth strategies to enhance its market dominance, such as product launches, approvals, mergers, collaboration and expansion. In April 2021, the company opened a new technology center in Schweinfurt for developing dialysis machines. In line with this, in November 2021, Fresenius launched new device CorAL which is a dialyzer for hemodialysis. In April 2020, Fresenius Medical Care North America collaborated with DaVita Inc. and other dialysis providers in response to COVID-19, which aimed to support the broader kidney care community in the United States. These strategic initiatives enable Fresenius Medical Care to secure a larger market share and strengthen its position in the urology devices market.
In 2022, Baxter International, Inc. (US) held a significant market share in the urology devices market. The company’s leading position can be attributed to its robust global sales and distribution network in around 100 countries, which effectively promotes its products across various countries. Baxter International has strategically emphasized research & development (R&D) initiatives to develop innovative and superior offerings compared to its competitors. By investing in R&D, the company aims to optimize its product portfolio and allocate capital wisely, thereby fostering future growth and maintaining its competitiveness.
Furthermore, Baxter International implements both organic strategies, such as regulatory approvals and product launches, to further strengthen its standing in the urology devices market. In November 2022, the company launched a hemodialysis device named HDx Therapy. This strategic move expanded the company’s product line considerably and enhanced its market visibility, bolstering its overall position in the industry. In April 2022, Baxter received U.S. FDA Clearance of ST Set used for renal replacement therapy.
Boston Scientific Corporation (US), a prominent player in the global urology devices market, secured a significant market share in the urology devices market in 2022. The company’s strong presence in North America, Europe, Asia Pacific, Middle East & Africa strengthens its geographical reach. Boston Scientific Corporation caters to a diverse customer base across various geographic locations. In addition to its R&D efforts and supply chain management, Boston Scientific leverages inorganic growth strategies to maintain its market leadership. For example, in December 2022, Boston Scientific acquired 65% stakes in Acotec Scientific Holdings Limited. Such developments contribute to the company’s continued success and its sustained leading position in the urology devices market.
Recent Developments of Urology Devices Industry
In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.
In December 2022, Boston Scientific Corporation (US) and Acotec Scientific Holdings Limited (China) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures.
In May 2022, B. Braun SE (Germany) entered into a distribution agreement, and B. Braun surgery division Aesculap has strengthened its long-term partnership with True Digital Surgery, a Californian company that is an expert in robotically controlled 3D digital visualization.
In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)
In April 2021, Becton, Dickinson and Company (US) announced an investment of USD 65 million for the construction of a state-of-the-art medical facility in Tucson, Arizona (US), which will serve as a final stage manufacturing and sterilization center to improve overall efficiency, customer service, and supply chain in the US.
Get 10% Free Customization on this Report:
Urology Devices Market Recent Developments:
In August 2023, Fresenius Medical Care AG & Co. KGaA (Germany), announced FDA Clearance for the product Versi HD with GuideMe Software.
In December 2022, Boston Scientific Corporation (US) and Acotec Scientific Holdings Limited (China) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures.
In May 2022, B. Braun SE (Germany) entered into a distribution agreement, and B. Braun surgery division Aesculap has strengthened its long-term partnership with True Digital Surgery, a Californian company that is an expert in robotically controlled 3D digital visualization.
In April 2022, Baxter International, Inc. (US) Announces U.S. FDA Clearance of ST Set used for renal replacement therapy (CRRT)
In April 2021, Becton, Dickinson and Company (US) announced an investment of USD 65 million for the construction of a state-of-the-art medical facility in Tucson, Arizona (US), which will serve as a final stage manufacturing and sterilization center to improve overall efficiency, customer service, and supply chain in the US.
Urology Devices Market - Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Rising incidence of urological diseases, growing preference for minimally invasive procedures, rising focus on R&D and product launches, growing number of hospitals and surgical centers), restraints (high degree of consolidation among key players), opportunities (potential growth opportunities in emerging economies, technological advancements) and challenges (increasing number of product recalls by key players, shortage of skilled urologists) influencing the growth of the urology devices market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the urology devices market.
Market Development: Comprehensive information about lucrative markets – the report analyses the urology devices market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.
#Global Urology Devices Market#Urology Devices Industry#Urology Devices Market Size#Urology Devices Market Growth#Urology Devices Market Outlook
0 notes
Link
0 notes